1-6 of 6
Alwyn D’Souza
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study

Clinical Trials & Observations
David T. Yeung, Naranie Shanmuganathan, John Reynolds, Susan Branford, Mannu Walia, Agnes S. M. Yong, Jake Shortt, Lynette Chee, Nicholas Viiala, Ilona Cunningham, David M. Ross, Alwyn D’Souza, Matthew Wright, Rosemary Harrup, Cecily Forsyth, Robin Filshie, Steven Lane, Peter Browett, Carolyn Grove, Andrew P. Grigg, Timothy P. Hughes
Journal: Blood
Blood (2024) 144 (19): 1993–2001.
https://doi.org/10.1182/blood.2024024657
Published: 2024
Includes: Supplemental data
Journal Articles

A Phase 1 Dose Escalation and Expansion Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Co-Stimulation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE-1)

Robert Weinkove, Philip George, Robert Fyfe, Aine Hurley, Nathaniel Dasyam, Yasmin Nouri, Tess Ostapowicz, Stefan Mullins, Giulia Giunti, Brittany Lavender, Brigitta Mester, Catherine M. Bollard, Travis Perera, Hayden Jina, Alwyn D'Souza, Le Qin, David S. Ritchie, Chris M.A. Frampton, Rachel Perret, Peng Li, Ian Hermans
Journal: Blood
Blood (2024) 144 (Supplement 1): 2067.
https://doi.org/10.1182/blood-2024-201138
Published: 2024
Journal Articles

Update of the Ascend-CML Study of Frontline Asciminib: High Rate of Optimal Response and Resistance Due to Mutations Is Rare

David T Yeung, Naranie Shanmuganathan, Agnes S. M. Yong, Jake Shortt, Lynette C.Y. Chee, Nicholas Vialla, Ilona Cunningham, David M Ross, Alwyn D'Souza, Matthew P.F. Wright, Rosemary Harrup, Cecily Forsyth, Robin Filshie, Steven W Lane, Peter J. Browett, Carolyn S. Grove, Mannu Walia, Susan Branford, John Reynolds, Andrew P Grigg, Timothy P Hughes
Journal: Blood
Blood (2024) 144 (Supplement 1): 476.
https://doi.org/10.1182/blood-2024-201218
Published: 2024
Journal Articles

A Phase 1 Dose Escalation Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Intracellular Domains for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE)

Robert Weinkove, Philip George, Robert Fyfe, Nathaniel Dasyam, Yasmin Nouri, Tess Ostapowicz, Stefan Mullins, Brigitta Mester, Giulia Giunti, Catherine M. Bollard, Travis Perera, Hayden Jina, Alwyn D'Souza, Le Qin, David S. Ritchie, Chris M.A. Frampton, Rachel Perret, Peng Li, Ian Hermans
Journal: Blood
Blood (2023) 142 (Supplement 1): 890.
https://doi.org/10.1182/blood-2023-178872
Published: 2023
Journal Articles

A  High- Risk Genetic Signature Is Predictive For Poor Outcome In Auto-Transplant Eigible Multiple Myeloma Patients Even With Use Of Novel Agents. A Single Institution Study

Kenneth R. Romeril, FRACP, FRCPA, Huib Buyck, Richard Parfitt, Catherine Wood, Alwyn d'Souza, Robert Weinkove, MA, FRCPath
Journal: Blood
Blood (2013) 122 (21): 5371.
https://doi.org/10.1182/blood.V122.21.5371.5371
Published: 2013
Journal Articles

Pax-5 Demonstrates Residual B-Cells in Bone Marrow Trephines Post Anti-CD20 Immunotherapy.

Alwyn D’Souza, MB, ChB, FRACP, Surender Juneja, MBBS, MD, FRCPA, Melanie Trivett, Dennis Carney, MBBS, FRACP, FRCPA, David Westerman, MBBS, FRACP, FRCPA
Journal: Blood
Blood (2005) 106 (11): 5013.
https://doi.org/10.1182/blood.V106.11.5013.5013
Published: 2005